Innovative fluorescence-based diagnostic system identifies early-stage bladder cancer with 90% accuracy, utilizing untreated ...

FUJIFILM Irvine Scientific, Inc., a global leader in the innovation and manufacture of cell culture solutions for the life science and medical markets, today announced it entered into an agreement to ...

A new study led by University of Arizona Mel and Enid Zuckerman College of Public Health researchers in collaboration with fire service partners and other researchers around the country through the ...

When is food simply nourishing and enjoyable, and when does it provoke an allergic reaction? The answer appears to lie in the ...

There was a 65% increase in the number of children and young people being admitted to general acute medical wards in hospitals in England because of a mental health concern between 2012 and 2022, ...

Patients with atrial fibrillation are typically prescribed an anticoagulant, or blood thinner, to reduce the risk of stroke, but many may discontinue them or never receive a prescription due to ...

Engineering and medical researchers at Penn have developed a groundbreaking framework that can determine the best and most ...

Investigators from Mass General Brigham​ have found that a method originally designed for cancer detection can also identify and monitor even tiny amounts of SARS-CoV-2 intact viral particles in blood ...

Researchers from Michigan State University's Department of Human Development and Family Studies revealed that sleep patterns may vary across different racial and ethnic groups - notably for non-white ...

Maternal vitamin D deficiency during pregnancy is linked to accelerated epigenetic gestational age in infants at birth, ...

Certain proteins found in the human brain have long been known to be critical to controlling how brain cells communicate with each other.

Insilico Medcine( "Insilico") , a clinical stage generative artificial intelligence (AI)-driven biotechnology company today announced the first patient has been dosed in the global multicenter Phase I ...